Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Coxbitor 200 - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Coxbitor 200

Approved

STANDARD

Coxbitor 200

Lloyd Laboratories, Inc🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 8f0e9dda6e81bb6b
Company: Lloyd Laboratories, Inc
Type: Standard

Approval Details

Approval Id: 8f0e9dda6e81bb6b
Drug Approval Philippines Name: Coxbitor 200
Product Name: Coxbitor 200
Registration Number: DRP-8481-01
Brand Name: Coxbitor 200
Generic Name: Celecoxib
Dosage Form: Capsule
Dosage Strength: 200 mg
Manufacturer: Lloyd Laboratories, Inc
Trader: Eadriex Pharmaceuticals Phils., Inc.
Distributor: Justright Healthcare Inc.
Issuance Date: 25 September 2024
Expiry Date: 01 December 2029
Pharmacologic Category: Selective COX-2 Inhibitor
Classification: Prescription Drug (Rx)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

8f0e9dda6e81bb6b

Type

Standard

Back to Philippines FDA Approvals